Publications

Less exacerbations and sustained asthma control 12 months after high altitude climate treatment for severe asthma.
Fieten KB, Rijssenbeek-Nouwens LH, Hashimoto S, Bel EH, Weersink EJ.
Allergy. 2019 Mar;74(3):628-630
PMID: 30428132

Preditors of treatment success in children with difficult tot treat atopic dermatitis using a personalized integrative multidisciplinary (PIM) treatment programme.
Fieten KB, Schappin R, Zijlstra WT, Rijssenbeek-Nouwens L, Meijer Y, Pasmans SGMA.
J Eur Acad Dermatol Venereol. 2019 Feb;33(2):376-383
PMID: 30198582

Preditors of benefit from high-altitude climate therapy in adults with severe asthma.
Hashimoto S, Rijssenbeek-Nouwens LH, Fieten KB, Weersink EJ, Bel EH.
Neth J Med. 2018 Jul;76(5):218-225
PMID: 30019677

Effectiveness of alpine climate treatment for children with difficult tot treat atopic dermatitis: Results of a pragmatic randomized controlled trial (DAVOS trial).
Fieten KB, Schappin R, Zijlstra WT, Figee L, Beutler J, Raymakers F, van Os-Medendorp H, Stellato R, Vandewall M, Winkelhof J, Uniken Venema M, Bruijnzeel-Koomen CAFM, Rijssenbeek-Nouwens L, van der Ent CK, van Hoffen E, Meijer Y, Pasmans SGMA.
Clin Exp Allergy. 2018 Feb;48(2):186-195
PMID: 29121432

Alpine climate treatment of atopic dermatitis: a systematic review.
Fieten KB, Weststrate AC, van Zuuren EJ, Bruijnzeel-Koomen CA, Pasmans SG.
Allergy 2015; 70:12-25.

Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial).Fieten KB, Zijlstra WT, van Os-Medendorp H, Meijer Y, Uniken Venema M, Rijssenbeek-Nouwens L, l’Hoir MP, Bruijnzeel-Koomen CA, Pasmans SGMA, et al.
Trials 2014; 15:94.

Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial).
Fieten KB, Zijlstra WT, van Os-Medendorp H, Meijer Y, Venema MU, Rijssenbeek-Nouwens L, l’Hoir MP, Bruijnzeel-Koomen CA, Pasmans SG.
Trials 2014 Mar 26;15:94.
PMID: 24670079

Health status measurement in patients with severe asthma.
Peters JB, Rijssenbeek-Nouwens LH, Bron AO, Fieten KB, Weersink EJ, Bel EH, Vercoulen JH.
Respir Med 2014;108:278-86.
PMID: 24361162

Risk of deep vein thrombosis and pulmonary embolism in asthma.
Majoor CJ, Kamphuisen PW, Zwinderman AH, Ten Brinke A, Amelink M, Rijssenbeek-Nouwens LH, Sterk PJ, Büller HR, Bel EH.
Eur Respir J. 2013 Sep;42(3):655-61
PMID: 23258790

High-altitude treatment in atopic and nonatopic patients with severe asthma.
Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Hashimoto S, Bel EH, Weersink EJ.
Eur Respir J 2012; 40:1374-80.
PMID: 22441741

High-altitude treatment: a therapeutic option for patients with severe, refractory asthma?
Rijssenbeek-Nouwens LH, Bel EH.
Clin Exp Allergy 2011; 41:775-82.
PMID: 21518039

Patients With Aspergillus Fumigatus-Associated Asthma Show Clinical Improvement At High Altitude.
Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Hashimoto S, Bel EH.
Am J Respir Crit Care Med 2011; 183, A1277.

Clinical improvement in patients with severe asthma at high altitude occurs irrespective of allergy to house dust mite.
Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Weersink EJ, Sterk PJ, Bel EH.
Am J Respir Crit Care Med 2010; 181, A5416.

Improvement in asthma control and decrease in FENO, whilst tapering the dose of oral corticosteroids during rehabilitation at high altitude in adults with severe asthma
Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Hashimoto S, Sterk PJ, Bel EH.
Am J Respir Crit Care Med 2009; 179, A2898.

How persistent is “persistent airflow limitation” in severe asthma.
Rijssenbeek-Nouwens LH, Bron AO, Naves C, Weller F, Weersink EJ, Bel EH.
Eur Respir J 2006; 28 (Suppl. 50).

Anti-allergic mattress covers in asthma: to do or not to do?
Rijssenbeek-Nouwens LH, Oosting AJ, Bruijnzeel-Koomen CA, de Bruin-Weller MS.
Clin Exp Allergy. 2003; 33:1613-7.
PMID: 14656344

Clinical evaluation of the effect of anti-allergic mattress covers in patients with moderate to severe asthma and house dust mite allergy: a randomised double blind placebo controlled study.
Rijssenbeek-Nouwens LH, Oosting AJ, de Bruin-Weller MS, Bregman I, de Monchy JG, Postma DS.
Thorax. 2002; 57:784-90.
PMID: 12200523

Assessing inpatient pulmonary rehabilitation using the patient’s view of outcome.
van Stel HF, Colland VT, Heins NL, Rijssenbeek-Nouwens LH, Everaerd W.
J Cardiopulm Rehabil. 2002; 22:201-10.
PMID: 12042690

The effect of anti-allergic mattress encasings on house dust mite-induced early- and late-airway reactions in asthmatic patients. A double-blind, placebo-controlled study.
Rijssenbeek-Nouwens LH, Oosting AJ, De Monchy JG, Bregman I, Postma DS, De Bruin-Weller MS.
Clin Exp Allergy. 2002; 32:117-25.
PMID: 12002728

Multivariable assessment of the 6-min walking test in patients with chronic obstructive pulmonary disease.
van Stel HF, Bogaard JM, Rijssenbeek-Nouwens LH, Colland VT.
Am J Respir Crit Care Med. 2001; 163:1567-71.
PMID: 11401875

Characteristics and diagnostic significance of spontaneous wheezing in children with asthma: results of continuous in vivo sound recording.
Rietveld S, Oud M, Rijssenbeek-Nouwens LH, Vaghi D, Dooijes EH.
J Asthma. 1999 Jun;36(4):351-8
PMID: 10386499

Cough as the ambiguous indicator of airway obstrutction in asthma.
Rietveld S, Rijssenbeek-Nouwens LH, Prins PJ.
J Asthma. 1999;36(2):177-86
PMID: 10227269

Diagnostics of spontaneous cough in childhood asthma: results of continuous tracheal sound recording in the homes of children.
Rietveld S, Rijssenbeek-Nouwens LH
Chest. 1998 Jan;113(1):50-4
PMID: 9440567

Allergen-induced changes in airway responsiveness are related to baseline airway responsiveness.
de Bruin-Weller MS, Weller FR, Rijssenbeek-Nouwens LH, Jansen HM, de Monchy JG.
Allergy. 1996; 51:401-6.
PMID: 8837663

Characteristics of wheeze during histamine-induced airways obstruction in children with asthma.
Rietveld S, Dooijes EH, Rijssenbeek-Nouwens LH, Smit F, Prins PJ, Kolk AM, Everaerd WA.
Thorax. 1995 Feb;50(2):143-8
PMID: 7701452

Lack of effect of cetirizine on early and late asthmatic response after allergen challenge.
De Bruin-Weller MS, Rijssenbeek-Nouwens LH, de Monchy JG.
J Allergy Clin Immunol. 1994 Aug;94(2 Pt 1):231-9
PMID: 8064075

Parental treatment management skills in pediatric atopic dermatitis.
Fieten KB, Bruins FM, Zijlstra WT, Schappin R, Figee L, de Bruijn M, Russel IMB, van Os- Medendorp H, Pasmans SGMA. Clinical and experimental dermatology in press.

Effectiveness of alpine climate treatment for children with difficult to treat atopic dermatitis: results of a pragmatic randomized controlled trial (DAVOS trial). Fieten KB, Schappin R, Zijlstra WT, Figee L, Beutler J, Raymakers F, van Os-Medendorp H, Stellato R, Vandewall M, Winkelhof J, Uniken Venema M, Bruijnzeel-Koomen C, Rijssenbeek- Nouwens L, van der Ent CK, van Hoffen E, Meijer Y, Pasmans SGMA. Clinical and Experimental Allergy, in press.

Interned-based self-management support after pulmonary rehabilitation of patients with severe asthma: a randomised controlled trial
Thijs Beerthuizen MD1, Lucia  Rijssenbeek-Nouwens MD PhD2, Jiska B. Snoeck-Stroband MD PhD1, Jacob K. Sont PhD1, submitted. European Respiratory Journal